Cargando…
Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD-L1 and MHC I in colon cancer cells
Topoisomerase inhibitors are clinically used to treat various cancer types, including colorectal cancer. These drugs also activate signaling pathways that modulate cell survival and immune cell functions. Immunotherapy is promising for certain tumors, including microsatellite instable colorectal can...
Autores principales: | Hassan, Mohamed, Trung, Vu, Bedi, Deepa, Shaddox, Sage, Gunturu, Dilip, Yates, Clayton, Datta, Pran, Samuel, Temesgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773314/ https://www.ncbi.nlm.nih.gov/pubmed/36589674 http://dx.doi.org/10.3892/ol.2022.13628 |
Ejemplares similares
-
Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells
por: Bedi, Deepa, et al.
Publicado: (2019) -
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
por: Vu, Trung, et al.
Publicado: (2017) -
Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell Lines
por: King, DeQuarius, et al.
Publicado: (2022) -
Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer
por: Vu, Trung, et al.
Publicado: (2016) -
MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer
por: Vu, Trung, et al.
Publicado: (2020)